Athersys is a late-stage biotechnology company developing their stem cell product MultiStem for multiple critical care indications.
Athersys is a late-stage biotechnology company developing their stem cell product MultiStem for multiple critical care indications.
Northwestern University scientists received top honors from the Clinical Research Forum as part of its 2020 Top Ten Clinical Research Achievement Awards program, taking home the associations highest honor and capturing more finalist nominations than any other institution. The remarkable success of these brilliant and dedicated investigators shows the strength and breadth of Northwesterns clinical research program and demonstrates our shared commitment as an institution to groundbreaking science that transforms human health, said Eric G.
As you were browsing http://www.streetinsider.com something about your browser made us think you were a bot. If you are interested in http://www.streetinsider.com content, APIs are available. Please contact us here http://www.streetinsider.com/signup_content.php After completing the CAPTCHA below, you will immediately regain access to http://www.streetinsider.com
XconomyBoston Driven by 20 years in the military, the CEO of Theradaptive hopes his firms regenerative paint technology platform can transform bone repair, spinal fusion, and sports medicine. The Boston-based firm, spun out of MIT, has a computational platform it says turns recombinant proteins into material-binding variants that behave like a paint. This can then be used to coat implants, devices, and injectable carriers to enable long-term local delivery without off-target effects.
PRINCETON, N.J. & ALAMEDA, Calif.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) and Exelixis, Inc. (NASDAQ: EXEL) today announced that CheckMate -9ER, a pivotal Phase 3 trial evaluating Opdivo (nivolumab) in combination with CABOMETYX(cabozantinib) compared to sunitinib in previously untreated advanced or metastatic renal cell carcinoma (RCC), met its primary endpoint of progression-free survival (PFS) at final analysis, as well as the secondary endpoints of overall survival (OS) at a pre-specified interim analysis, and objective response rate (ORR)
"Viral vector manufacturing has transitioned from a niche industry to the cornerstone of the future of biopharmaceuticals," said Udit Batra, member of the Merck Executive Board and CEO, Life Science. "Few companies have the scale and quality systems in place for manufacturing commercial viral vector products.
NEW YORK, April 15, 2020 /PRNewswire/ -- The stem cell therapy market was valued at US$ 1,534.55 million in 2019 and is estimated to reach US$ 5,129.66 million by 2027; it is expected to grow at a CAGR of 16.7% from 2020 to 2027.
PETITION: Pres. Trump don't give federal funds to COVID-19 vaccines made from aborted baby cellsSign the petition here.
The Cord Stem Cell Banking Market report offers a complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global Cord Stem Cell Banking market. The market report is sure to lend a hand in enhancing sales and improving return on investment (ROI).
Documenting the Industry Development of Stem Cells Cryopreservation Equipments Market concentrating on the industry that holds a massive market share 2020 both concerning volume and value With top countries data, Manufacturers, Suppliers, In-depth research on market dynamics, export research report and forecast to 2029 As per the report, the Stem Cells Cryopreservation Equipments Market is anticipated to gain substantial returns while registering a profitable annual growth rate during the predicted time period.The global stem cells cryopreservation equipments market research report takes a chapter-wise approach in explaining the dynamics and trends in the stem cells cryopreservation equipments industry.The report also provides the industry growth with CAGR in the forecast to 2029. A deep analysis of microeconomic and macroeconomic factors affecting the growth of the market are also discussed in this report.
Recent Comments